Condition: Healthy Adult · Sponsor: MODAG GmbH
This is an open-label, single-center, phase 1 study to further characterize \[18F\]MODAG-009 in Healthy Volunteers (HV). Approximately 6 participants will be enrolled in this study. Each participant will receive a single dose of \[18F\]MODAG-009 radiotracer and undergo whole body PET imaging covering up to 10 bed positions to capture the whole body from skull vertex to mid-thigh.
This description comes directly from the study's public registry record.
Johannes Levin, MD · 475-318-8250 · levin@modag.net
Stephanie Roman · 475-318-8250 · sroman@xingimaging.com
Always discuss trial participation with your own doctor first.
| Institute for Neurodegenerative Disorders and XingImaging, LLC | New Haven, Connecticut, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07617688